TMO240628C400000
- 0.00
- 0.000.00%
Thermo Fisher Scientific Newsroom
Thermo Fisher Is Maintained at Equal-Weight by Barclays
Thermo Fisher Is Maintained at Equal-Weight by Barclays
Thermo Fisher Scientific Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 8.38% Barclays $615 → $600 Maintains Equal-Weight 06/03/2024 17.41% Jefferies $600 → $650 Assum
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Thermo Fisher Scientific Introduces Biobased Solutions to Help Reduce Climate Impact in Manufacturing of Therapies
New solutions include a first-of-its-kind film that can eliminate carbon emissions from plastic resin Thermo Fisher Scientific Inc., the world leader in serving science, is contributing to the sustainability of
Express News | Thermo Fisher Scientific : Barclays Cuts Target Price to $600 From $615
Barclays Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating, Cuts Target Price to $600
Barclays analyst Luke Sergott maintains $Thermo Fisher Scientific(TMO.US)$ with a hold rating, and adjusts the target price from $615 to $600.According to TipRanks data, the analyst has a success rate
Germany In Vitro Fertilization Market Research 2024-2030 Featuring Bayer, Cook Medical, VivaNeo, Ferring, Genea Biomedx, EMD Serono, Merck, Thermo Fisher Scientific, & Vitrolife
Express News | Thermo Fisher Scientific : $47.8 Mln Investment Is Expected to Create More Than 250 New Jobs Across Two Sites Over Next Eight Years
Express News | Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky
Thermo Fisher's (TMO) New Launch Speeds Up PDNA Purification
Barclays Adjusts Price Target on Thermo Fisher Scientific to $600 From $615
Thermo Fisher Scientific (TMO) has an average rating of outperform and price targets ranging from $553 to $677, according to analysts polled by Capital IQ. Price: 556.97, Change: -1.20, Percent Change
Labguru (BioData) Announces New Distribution Partnership of Its Electronic Lab Notebook Module to Help Streamline Life Sciences Research
New distribution agreement with Thermo Fisher Scientific allows Thermo Fisher to offer Labguru's cutting-edge Electronic Lab Notebook module together with Thermo Fisher's renowned suite of Laboratory
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies
Thermo Scientific KingFisher PlasmidPro prepares high purity plasmid DNA in approximately 75 minutes, half the traditional process time and without the need for centrifugation Thermo Fisher Scientific
What the Options Market Tells Us About Thermo Fisher Scientific
Investors with significant funds have taken a bullish position in Thermo Fisher Scientific (NYSE:TMO), a development that retail traders should be aware of.This was brought to our attention today thro
Thermo-Fisher Scientific Inc. (TMO): Did This Healthcare Stock Exceed Expectations in Q1?
RBC Trims Price Target on Thermo Fisher Scientific to $660 From $662, Keeps Outperform Rating
Thermo Fisher Scientific (TMO) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $553 to $677. Price: 565.00, Change: +0.40, Percent C
Express News | Thermo Fisher Scientific Inc : RBC Cuts Target Price to $660 From $662
Declining Stock and Solid Fundamentals: Is The Market Wrong About Thermo Fisher Scientific Inc. (NYSE:TMO)?
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
Catalent shares rise after Sarepta Therapeutics' Elevidys expanded approval. Despite uncertainties, Catalent's risk/reward profile improves.
Express News | Shares of Thermo Fisher Scientific up 1.7% After FDA's Expanded Use Nod for Sarepta's Duchenne Gene Therapy